These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 3596807)

  • 1. Polymorphonuclear neutrophil chemotaxis modulated by Bacteroides fragilis peptidoglycan.
    Sperry JF; Burns JM
    Infect Immun; 1987 Jul; 55(7):1725-7. PubMed ID: 3596807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Bacteroides fragilis cellular components on chemotactic activity of polymorphonuclear leukocytes towards Escherichia coli.
    Namavar F; Verweij-Van Vught AM; Bal M; MacLaren DM
    J Med Microbiol; 1987 Sep; 24(2):119-24. PubMed ID: 3309320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymorphonuclear neutrophil chemotaxis induced and inhibited by Bacteroides spp.
    Adamu SA; Sperry JF
    Infect Immun; 1981 Sep; 33(3):806-10. PubMed ID: 7287183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymorphonuclear leukocyte chemotaxis by mixed anaerobic and aerobic bacteria.
    Namavar F; Verweij-Van Vught AM; Vel WA; Bal M; MacLaren DM
    J Med Microbiol; 1984 Oct; 18(2):167-72. PubMed ID: 6387126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Bacteroides by-product inhibits human polymorphonuclear leukocyte function.
    Rotstein OD; Pruett TL; Sorenson JJ; Fiegel VD; Nelson RD; Simmons RL
    Arch Surg; 1986 Jan; 121(1):82-8. PubMed ID: 3942502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interactions of Bacteroides fragilis and phagocytes: studies with whole organisms, purified capsular polysaccharide and clindamycin-treated bacteria.
    Wade BH; Kasper DL; Mandell GL
    J Antimicrob Chemother; 1983 Oct; 12 Suppl C():51-62. PubMed ID: 6643341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The chemotactic effect of Bacteroides fragilis lipopolysaccharide.
    Hofstad T; Sveen K
    Rev Infect Dis; 1979; 1(2):342-6. PubMed ID: 549186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rabbit polymorphonuclear leukocyte chemotactic factor generated in vivo by Bacteroides fragilis lipopolysaccharide. I. Isolation and physico-chemical characterization.
    Sveen K
    Acta Pathol Microbiol Scand B; 1978 Aug; 86(4):229-36. PubMed ID: 358747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of humoral factors in host resistance to the Bacteroides fragilis group.
    Bjornson AB
    Rev Infect Dis; 1990; 12 Suppl 2():S161-8. PubMed ID: 2406868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Killing of Escherichia coli by human polymorphonuclear leucocytes in the presence of Bacteroides fragilis.
    Vel WA; Namavar F; Verweij-van Vught AM; Pubben AN; MacLaren DM
    J Clin Pathol; 1985 Jan; 38(1):86-91. PubMed ID: 3881478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bacteroides and Staphylococcus glycocalyx: chemical analysis, and the effects on chemiluminescence and chemotaxis of human polymorphonuclear leucocytes.
    Ferguson DA; Veringa EM; Mayberry WR; Overbeek BP; Lambe DW; Verhoef J
    Microbios; 1992; 69(278):53-65. PubMed ID: 1588843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rabbit polymorphonuclear leukocyte chemotactic factor generated in vivo by Bacteroides fragilis lipopolysaccharide. II. Antigenic and biologic properties.
    Sveen K
    Acta Pathol Microbiol Scand B; 1978 Aug; 86(4):237-45. PubMed ID: 99978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Succinic acid production by Bacteroides fragilis. A potential bacterial virulence factor.
    Rotstein OD; Wells CL; Pruett TL; Sorenson JJ; Simmons RL
    Arch Surg; 1987 Jan; 122(1):93-8. PubMed ID: 3800654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alterations in opsonophagocytic killing by neutrophils of Bacteroides fragilis associated with animal and laboratory passage: effect of capsular polysaccharide.
    Simon GL; Klempner MS; Kasper DL; Gorbach SL
    J Infect Dis; 1982 Jan; 145(1):72-7. PubMed ID: 7054319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemotaxis or migration inhibition of rabbit peritoneal polymorphonuclear leukocytes caused by chemoattractants at various concentrations.
    Sveen K
    Acta Pathol Microbiol Scand B; 1979 Oct; 87(5):285-90. PubMed ID: 525354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bactericidal activity of a granule extract from human polymorphonuclear leukocytes against Bacteroides species.
    Pruul H; Wetherall BL; McDonald PJ
    Infect Immun; 1983 Sep; 41(3):1373-5. PubMed ID: 6885166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogenic synergy: mixed intra-abdominal infections.
    MacLaren DM; Namavar F; Verweij-Van Vught AM; Vel WA; Kaan JA
    Antonie Van Leeuwenhoek; 1984; 50(5-6):775-87. PubMed ID: 6397140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactions of polymorphonuclear leukocytes with anaerobic bacteria.
    Klempner MS
    Rev Infect Dis; 1984; 6 Suppl 1():S40-4. PubMed ID: 6372036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specificity of immunoglobulin M antibodies in normal human serum that participate in opsonophagocytosis and intracellular killing of Bacteroides fragilis and Bacteroides thetaiotaomicron by by human polymorphonuclear leukocytes.
    Bjornson AB; Bjornson HS; Kitko BP
    Infect Immun; 1980 Oct; 30(1):263-71. PubMed ID: 6160104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemotaxis by lipids isolated from Bacteroides fragilis.
    Adebiyi RF; Campbell BJ; Hentges DJ; Barrett JT
    Afr J Med Med Sci; 1979; 8(3-4):139-45. PubMed ID: 122317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.